BBA and Xtrakter have published a response to CESR’s consultation on transaction reports for OTC derivatives. They support extending the existing reporting regime to include OTC instruments whose value is derived from instruments admitted to trading on a regulated market. They also stress the current framework is not suitable for monitoring systemic risk as it was designed for market abuse surveillance. The response also supports a “user pack” but says the pack must contain enough detail to be practical.